Based on the overexpression of KLK6 in both rat OSCC and several types of human malignancies [30–33], a similar argument can be made in support of further oral cancer chemoprevention studies with serine protease inhibitors. This evidence concerns the gene KLK6 and lip and oral cavity carcinoma.